145 related articles for article (PubMed ID: 31413091)
1. Disappearance of slan-positive non-classical monocytes for diagnosis of chronic myelomonocytic leukemia with associated inflammatory state.
Tarfi S; Badaoui B; Freynet N; Morabito M; Lafosse J; Toma A; Etienne G; Micol JB; Sloma I; Fenaux P; Solary E; Selimoglu-Buet D; Wagner-Ballon O;
Haematologica; 2019 Aug; ():. PubMed ID: 31413091
[No Abstract] [Full Text] [Related]
2. Reduced Percentage of CD14
Kowalska W; Zarobkiewicz M; Tomczak W; Woś J; Morawska I; Bojarska-Junak A
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328450
[TBL] [Abstract][Full Text] [Related]
3. 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes.
Hofer TP; van de Loosdrecht AA; Stahl-Hennig C; Cassatella MA; Ziegler-Heitbrock L
Front Immunol; 2019; 10():2052. PubMed ID: 31572354
[TBL] [Abstract][Full Text] [Related]
4. Incorporating flow cytometry and next-generation sequencing in the diagnosis of CMML. Are we ready for prime?
Solary E; Wagner-Ballon O; Selimoglu-Buet D
Best Pract Res Clin Haematol; 2020 Jun; 33(2):101134. PubMed ID: 32460985
[TBL] [Abstract][Full Text] [Related]
5. slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutation.
Hofer TP; Zawada AM; Frankenberger M; Skokann K; Satzl AA; Gesierich W; Schuberth M; Levin J; Danek A; Rotter B; Heine GH; Ziegler-Heitbrock L
Blood; 2015 Dec; 126(24):2601-10. PubMed ID: 26443621
[TBL] [Abstract][Full Text] [Related]
6. Pro- vs. Anti-Inflammatory Features of Monocyte Subsets in Glioma Patients.
Lehman N; Kowalska W; Zarobkiewicz M; Mazurek M; Mrozowska K; Bojarska-Junak A; Rola R
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768201
[TBL] [Abstract][Full Text] [Related]
7. The slan antigen identifies the prototypical non-classical CD16
Tamassia N; Bianchetto-Aguilera F; Gasperini S; Grimaldi A; Montaldo C; Calzetti F; Gardiman E; Signoretto I; Castellucci M; Barnaba V; Tripodi M; Cassatella MA
Front Immunol; 2023; 14():1287656. PubMed ID: 37965335
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the fate of slan
Bianchetto-Aguilera F; Tamassia N; Gasperini S; Calzetti F; Finotti G; Gardiman E; Montioli R; Bresciani D; Vermi W; Cassatella MA
FASEB J; 2020 Jul; 34(7):9269-9284. PubMed ID: 32413173
[TBL] [Abstract][Full Text] [Related]
9. Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes.
Van Leeuwen-Kerkhoff N; Westers TM; Poddighe PJ; Povoleri GAM; Timms JA; Kordasti S; De Gruijl TD; Van de Loosdrecht AA
Haematologica; 2022 Mar; 107(3):655-667. PubMed ID: 33567812
[TBL] [Abstract][Full Text] [Related]
10. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.
Geyer JT; Tam W; Liu YC; Chen Z; Wang SA; Bueso-Ramos C; Oak J; Arber DA; Hsi E; Rogers HJ; Levinson K; Bagg A; Hassane DC; Hasserjian RP; Orazi A
Mod Pathol; 2017 Sep; 30(9):1213-1222. PubMed ID: 28548124
[TBL] [Abstract][Full Text] [Related]
11. Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults.
Zandberg DP; Huang TY; Ke X; Baer MR; Gore SD; Smith SW; Davidoff AJ
Haematologica; 2013 Apr; 98(4):584-90. PubMed ID: 23144192
[TBL] [Abstract][Full Text] [Related]
12. Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.
Gelsi-Boyer V; Cervera N; Bertucci F; Brecqueville M; Finetti P; Murati A; Arnoulet C; Mozziconacci MJ; Mills KI; Cross NC; Vey N; Birnbaum D
Haematologica; 2013 Apr; 98(4):576-83. PubMed ID: 23065512
[TBL] [Abstract][Full Text] [Related]
13. ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry.
Wagner-Ballon O; Bettelheim P; Lauf J; Bellos F; Della Porta M; Travaglino E; Subira D; Lopez IN; Tarfi S; Westers TM; Johansson U; Psarra K; Karathanos S; Matarraz S; Colado E; Gupta M; Ireland R; Kern W; Van De Loosdrecht AA;
Cytometry B Clin Cytom; 2023 Jan; 104(1):66-76. PubMed ID: 34967500
[TBL] [Abstract][Full Text] [Related]
14. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional profiling reveals functional dichotomy between human slan
van Leeuwen-Kerkhoff N; Lundberg K; Westers TM; Kordasti S; Bontkes HJ; de Gruijl TD; Lindstedt M; van de Loosdrecht AA
J Leukoc Biol; 2017 Oct; 102(4):1055-1068. PubMed ID: 28720687
[TBL] [Abstract][Full Text] [Related]
16. Clinical Utility of Classical and Nonclassical Monocyte Percentage in the Diagnosis of Chronic Myelomonocytic Leukemia.
Hudson CA; Burack WR; Leary PC; Bennett JM
Am J Clin Pathol; 2018 Aug; 150(4):293-302. PubMed ID: 29982327
[TBL] [Abstract][Full Text] [Related]
17. Real world implementation of flow cytometric monocyte subset partitioning for distinguishing chronic myelomonocytic leukaemia from other causes of monocytosis.
Barge L; Gooch M; Hendle M; Simleit E
Pathology; 2023 Oct; 55(6):827-834. PubMed ID: 37541805
[TBL] [Abstract][Full Text] [Related]
18. Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis.
Tarfi S; Harrivel V; Dumezy F; Guy J; Roussel M; Mimoun A; Fenaux P; Chapuis N; Solary E; Selimoglu-Buet D; Wagner-Ballon O;
Blood Cancer J; 2018 Nov; 8(11):114. PubMed ID: 30429467
[TBL] [Abstract][Full Text] [Related]
19. Conventional Dendritic Cells and Slan
Iannetta M; Isnard S; Manuzak J; Guillerme JB; Notin M; Bailly K; Andrieu M; Amraoui S; Vimeux L; Figueiredo S; Charmeteau-de Muylder B; Vaton L; Hatton EX; Samri A; Autran B; Thiébaut R; Chaghil N; Glohi D; Charpentier C; Descamps D; Brun-Vézinet F; Matheron S; Cheynier R; Hosmalin A
Front Immunol; 2020; 11():1658. PubMed ID: 32903610
[TBL] [Abstract][Full Text] [Related]
20. High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screening.
Vazquez R; Roussel M; Badaoui B; Freynet N; Tarfi S; Solary E; Selimoglu-Buet D; Wagner-Ballon O;
Cytometry B Clin Cytom; 2018 Sep; 94(5):658-661. PubMed ID: 29108126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
